Financials International Company For Medical Industries S.A.E.
Equities
ICMI
EGS3I0S1C019
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.545 EGP | -.--% |
|
-.--% | -.--% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 4.06 | 6.68 | 6.186 | 2.189 | 1.075 | 11.97 |
EBITDA 1 | 0.6949 | 0.6425 | 0.8924 | 0.7705 | 0.3391 | 0.5392 |
EBIT 1 | 0.388 | -0.0553 | 0.1019 | -0.0615 | -0.4866 | -0.2861 |
Operating Margin | 9.56% | -0.83% | 1.65% | -2.81% | -45.29% | -2.39% |
Earnings before Tax (EBT) 1 | 0.4358 | 0.5637 | 0.0518 | 0.0156 | -0.0514 | 0.8708 |
Net income 1 | 0.2994 | 0.3867 | 0.047 | 0.034 | -0.0913 | 0.9186 |
Net margin | 7.37% | 5.79% | 0.76% | 1.55% | -8.5% | 7.67% |
EPS 2 | 0.0202 | 0.0129 | 0.001573 | 0.001139 | -0.003775 | 0.0159 |
Free Cash Flow 1 | -0.2117 | -10.83 | -3.336 | -1.45 | -1.168 | -23.31 |
FCF margin | -5.22% | -162.09% | -53.93% | -66.25% | -108.66% | -194.7% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/03/18 | 21/02/19 | 01/03/20 | 04/03/21 | 03/03/22 | 01/03/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.28 | - | 0.87 | 2.22 | - | - |
Net Cash position 1 | - | 0.72 | - | - | 32.1 | 9.24 |
Leverage (Debt/EBITDA) | 1.84 x | - | 0.9788 x | 2.886 x | - | - |
Free Cash Flow 1 | -0.21 | -10.8 | -3.34 | -1.45 | -1.17 | -23.3 |
ROE (net income / shareholders' equity) | 2.21% | 1.93% | 0.18% | 0.13% | -0.21% | 1.52% |
ROA (Net income/ Total Assets) | 1.03% | -0.12% | 0.19% | -0.11% | -0.59% | -0.27% |
Assets 1 | 29.02 | -331 | 25.15 | -30.19 | 15.46 | -341.5 |
Book Value Per Share 2 | 1.140 | 1.090 | 1.090 | 1.090 | 2.490 | 1.050 |
Cash Flow per Share 2 | 0 | 0.0800 | 0.0200 | 0 | 1.420 | 0.1700 |
Capex 1 | 0.65 | 3.08 | 6.25 | - | - | 0.9 |
Capex / Sales | 16.01% | 46.1% | 100.96% | - | - | 7.54% |
Announcement Date | 11/03/18 | 21/02/19 | 01/03/20 | 04/03/21 | 03/03/22 | 01/03/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 18.68L | |
+32.96% | 259.73Cr | |
-41.52% | 258.03Cr | |
+7.15% | 223.5Cr | |
-26.39% | 220.68Cr | |
+30.00% | 198.63Cr | |
-9.37% | 190.95Cr | |
+35.14% | 135.21Cr | |
+0.84% | 128.71Cr | |
+16.41% | 125.05Cr |
- Stock Market
- Equities
- ICMI Stock
- Financials International Company For Medical Industries S.A.E.